Enhanced Dual‐Modality CT Imaging for Evaluating Hematogenous Metastasis During Photothermal Therapy
Abstract
ABSTRACT Dynamic assessment of hematogenous metastasis is crucial for the tumor during photothermal therapy. However, detecting tumor microvessels and quantifying microvascular hemodynamics remain challenging using clinical CT imaging. Here, we introduce an innovative approach that integrates enhanced anatomical imaging (spectral CT angiography and spectral CTA) with functional imaging (CT perfusion and CTP) to evaluate tumor microvasculature and metastasis. We develop BiF 3 @PDA@PEG (BPP) nanoagents with a photothermal conversion efficiency of 24.1% to kill tumors. More importantly, BPP nanoagents can characteristically absorb X‐rays at 40 keV in spectral CT imaging to generate a significant CT enhancement ability of 122.9 HU/2000 ppm. Leveraging these advantages, the tumor microvessels as small as 627.0 μm in diameter can be clearly observed, and the dynamic changes in vascular permeability with a reduction of 77.17% can be clearly displayed after complete photothermal ablation. A positive correlation of 97.58% between vascular CT values and metastasis progression is also observed, indicating the potential of enhanced dual‐modality CT imaging with BPP nanoagents for predicting and monitoring metastasis. This approach offers a new paradigm for both the evaluation of therapeutic efficacy and the prediction of metastasis in tumors.